CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 68 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $495 | -50.5% | 4,479 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 4,479 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -50.0% | 4,479 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | -33.3% | 4,479 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | -40.0% | 4,479 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $5,000 | -37.5% | 4,479 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $8,000 | -11.1% | 4,479 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $9,000 | -25.0% | 4,479 | -55.1% | 0.01% | -30.0% |
| Q4 2020 | $12,000 | -33.3% | 9,980 | 0.0% | 0.01% | -37.5% |
| Q3 2020 | $18,000 | -78.6% | 9,980 | 0.0% | 0.02% | -82.6% |
| Q2 2020 | $84,000 | +61.5% | 9,980 | 0.0% | 0.09% | +46.0% |
| Q1 2020 | $52,000 | – | 9,980 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 397,168 | $43,888 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $3,366 | 0.00% |
| Tekla Capital Management LLC | 154,310 | $17,051 | 0.00% |
| McAdam, LLC | 10,006 | $6 | 0.00% |
| Aries Wealth Management | 15,400 | $1,702 | 0.00% |
| WELLS FARGO & COMPANY/MN | 342,084 | $37,800 | 0.00% |
| JPMORGAN CHASE & CO | 43,415 | $5 | 0.00% |
| NORTHERN TRUST CORP | 207,329 | $22,910 | 0.00% |
| PINNACLE ASSOCIATES LTD | 18,580 | $2,053 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |